Catalyst Wire Dossier Catalyst Wire Dossier

Fixed-dose combination tablet (maraviroc + lamivudine/zidovudine)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fixed-dose combination tablet (maraviroc + lamivudine/zidovudine), covering 2012-05-21 to 2012-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ [Phase 1]

See pricing